Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
URGN compared with CADL: revenue, margins and what each company keeps, and the suppliers and customers both name
URGN
UroGen Pharma Ltd.
Change
Mkt cap
Revenue
Revenue
CADL
Candel Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
URGN
UroGen Pharma Ltd.
vs
CADL
Candel Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
URGN
UroGen Pharma Ltd.
Change
32.70
▼
−4.83%
· post 34.42
Mkt cap
$1.7B
Revenue
$72M
Q2 FY26
Revenue
$110M
FY25
CADL
Candel Therapeutics, Inc.
Change
8.83
▲
+8.68%
· post 8.95
Closed
Nov 3 '26
Mkt cap
$621.3M
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 3 '26
URGN
UroGen Pharma Ltd.
vs
CADL
Candel Therapeutics, Inc.
32.70
▼
−4.83%
post 34.42
Price
8.83
▲
+8.68%
post 8.95
$1.7B
Mkt cap
$621.3M
Q2 FY26
$72M
Revenue
—
FY25
$110M
Revenue
—
Change
Change
URGN
32.70
▼
−4.83%
vs
CADL
8.83
▲
+8.68%
Closed
Nov 3 '26
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
URGN, solid
CADL, dashed